Matrix controlled transdermal therapeutic system for the use of pramipexole and ropinirole

US7344733B2 · kind B2 · utility

Assignee

• Hexal AG · DE

Inventors

• Cornelia Beier · Holzkirchen, DE
• Martina Wilhelm · Holzkirchen, DE

Key dates

• Filing date: Jul 26, 2002
• Grant date: Mar 18, 2008
• Expiry date: Apr 13, 2024

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/7061
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to an active-ingredient-containing, matrix-controlled transdermal therapeutic system for the use of pramipexole, ropinirole, pharmaceutically acceptable salts thereof or pharmaceutically acceptable derivatives thereof.